Caseware UK (AP4) 2023.0.135 2023.0.135 false3falsetrue2023-07-013The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 13229249 2023-07-01 2024-06-30 13229249 2022-07-01 2023-06-30 13229249 2024-06-30 13229249 2023-06-30 13229249 c:Director1 2023-07-01 2024-06-30 13229249 c:Director2 2023-07-01 2024-06-30 13229249 d:FreeholdInvestmentProperty 2024-06-30 13229249 d:FreeholdInvestmentProperty 2023-06-30 13229249 d:CurrentFinancialInstruments 2024-06-30 13229249 d:CurrentFinancialInstruments 2023-06-30 13229249 d:CurrentFinancialInstruments d:WithinOneYear 2024-06-30 13229249 d:CurrentFinancialInstruments d:WithinOneYear 2023-06-30 13229249 d:Non-currentFinancialInstruments d:AfterOneYear 2024-06-30 13229249 d:Non-currentFinancialInstruments d:AfterOneYear 2023-06-30 13229249 d:ShareCapital 2024-06-30 13229249 d:ShareCapital 2023-06-30 13229249 d:RetainedEarningsAccumulatedLosses 2024-06-30 13229249 d:RetainedEarningsAccumulatedLosses 2023-06-30 13229249 c:FRS102 2023-07-01 2024-06-30 13229249 c:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 13229249 c:FullAccounts 2023-07-01 2024-06-30 13229249 c:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 13229249 2 2023-07-01 2024-06-30 iso4217:GBP xbrli:pure
Registered number: 13229249













Lakeland Medical Holdings Limited

Financial statements
Information for filing with the registrar

30 June 2024




 
Lakeland Medical Holdings Limited


Balance sheet
At 30 June 2024

2024
2023
Note
£
£

Fixed assets
  

Investments
 4 
516,834
516,834

Investment property
 5 
239,526
239,526

  
756,360
756,360

Current assets
  

Debtors
 6 
31,819
-

Cash at bank and in hand
  
74,580
161,282

  
106,399
161,282

Creditors: amounts falling due within one year
 7 
(133,830)
(211,498)

Net current liabilities
  
 
 
(27,431)
 
 
(50,216)

Total assets less current liabilities
  
728,929
706,144

Creditors: amounts falling due after more than one year
  
(599,912)
(624,892)

Provisions for liabilities
  

Deferred tax
  
(2,994)
(2,994)

Net assets
  
126,023
78,258


Capital and reserves
  

Called up share capital 
  
300
300

Profit and loss account
  
125,723
77,958

Shareholders' funds
  
126,023
78,258


1

 
Lakeland Medical Holdings Limited

    
Balance sheet (continued)
At 30 June 2024

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The company's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 19 March 2025.




N L Craddock
B Vitorino
Director
Director

Company registered number: 13229249
The notes on pages 3 to 5 form part of these financial statements. 

2

 
Lakeland Medical Holdings Limited
 
 

Notes to the financial statements
Year ended 30 June 2024

1.


General information

Lakeland Medical Holdings Limited ('the company') is a private company limited by shares, incorporated and domiciled in the United Kingdom and registered in England and Wales. The address of the registered office is Citygate, St James' Boulevard, Newcastle upon Tyne, Tyne and Wear, NE1 4JE.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Revenue

The turnover in the profit and loss account represents rent receivable during the period.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.


3.


Employees

The average monthly number of employees, including the directors, during the year was 3 (2023: 3).


4.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 July 2023
516,834



At 30 June 2024
516,834




3

 
Lakeland Medical Holdings Limited
 
 

Notes to the financial statements
Year ended 30 June 2024

5.


Investment property


Freehold investment property

£



Valuation


At 1 July 2023
239,526



At 30 June 2024
239,526

In the opinion of the Directors, valuation of the investment property is fair and unlikely to represent a material difference to true valuation.








6.


Debtors

2024
2023
£
£


Amounts owed by group undertakings
31,819
-

31,819
-



7.


Creditors: amounts falling due within one year

2024
2023
£
£

Bank loans
26,466
27,953

Amounts owed to group undertakings
105,000
181,181

Other creditors
324
324

Accruals and deferred income
2,040
2,040

133,830
211,498


4

 
Lakeland Medical Holdings Limited
 
 

Notes to the financial statements
Year ended 30 June 2024

8.


Related party transactions

During the year, the company operated on normal commercial terms with Alistair Morgan & Associates Limited. The amount owed from Alistair Morgan & Associates Limited at 30 June 2024 was £31,819 (2023: £76,181 owed to Alistair Morgan & Associates Limited).
During the year, the company operated on normal commercial terms with Cartmell Medical Services Limited. The amount owed to Cartmell Medical Services Limited at 30 June 2024 was £35,000 (2023: £35,000).
During the year, the company operated on normal commercial terms with Vitorino Limited. The amount owed to Vitorino Limited at 30 June 2024 was £70,000 (2023: £70,000).

 
5